Security National Bank’s Cardiff Oncology CRDF Stock Holding History

Security National Bank’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.7K	Hold	9,767	–	–	﹤0.01%	314
2026 Q1	$15.8K	Hold	9,767	–	–	﹤0.01%	307
2025 Q4	$27.4K	Hold	9,767	–	–	﹤0.01%	266
2025 Q3	$20.1K	Hold	9,767	–	–	﹤0.01%	284
2025 Q2	$30.8K	Hold	9,767	–	–	0.01%	241
2025 Q1	$30.7K	Hold	9,767	–	–	0.01%	241
2024 Q4	$42.4K	Hold	9,767	–	–	0.01%	219
2024 Q3	$26.1K	Hold	9,767	–	–	﹤0.01%	224
2024 Q2	$21.7K	Hold	9,767	–	–	﹤0.01%	228
2024 Q1	$52.2K	Hold	9,767	–	–	0.01%	188
2023 Q4	$14.5K	Buy	+9,767	New	+$11.8K	﹤0.01%	243
2019 Q1	–	Sell	-6,867	Closed	-$22K	–	74
2018 Q4	$22K	Hold	6,867	–	–	0.01%	65
2018 Q3	$34K	Hold	6,867	–	–	0.02%	63
2018 Q2	$32K	Buy	+6,867	New	+$115K	0.02%	61

Other funds holding CRDF

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Security National Bank's CRDF Position: Q2 2026 in Review

Security National Bank held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 9,767 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Security National Bank first reported a position in CRDF in Q2 2018 and has held it in 14 quarters since. The position peaked at $52.2K in Q1 2024. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

Security National Bank held 9,767 shares of Cardiff Oncology worth $12.7K as of Q2 2026.
Security National Bank left its Cardiff Oncology share count unchanged in Q2 2026.
Cardiff Oncology made up ﹤0.01% of Security National Bank's portfolio in Q2 2026, its #314 holding.
Security National Bank first reported a position in Cardiff Oncology in Q2 2018 and has held it in 14 quarters since.
Security National Bank's Cardiff Oncology position peaked at $52.2K in Q1 2024.
105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Security National Bank's 13F filing for Q2 2026, filed 15 Jul 2026.